Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Pharma’s four options for innovation

Only genuinely creative companies will profit from the future

- PMLiVE

MHRA received 286 advertising complaints in 2013

UK medicines regulator publishes annual report

- PMLiVE

GSK takes drug hunter challenge into Europe

Invites academics to submit partnership proposals

- PMLiVE

NICE backs new use for Bayer’s Eylea

Will go up against Novartis’ Lucentis in treatment of macular oedema in UK

- PMLiVE

AZ gets limited approval for metreleptin in US

First FDA-backed treatment for rare disease lipodystrophy

- PMLiVE

GSK’s Lawson elected PAGB president

He will help lead OTC trade body after departure of Novartis' David Barnett

- PMLiVE

Serviceplan ranks top among German creative agencies

Beats Peix Healthcare Communications and Schmittgall in magazine ranking

- PMLiVE

Biosimilars: friend or foe for healthcare systems?

An opportunity in Europe, but widespread acceptance and uptake is by no means a done deal

- PMLiVE

WCCT Global talks up orphan drug benefits of new service

CRO's In-Site programme will harness digital technology for patient recruitment

- PMLiVE

INC Research appoints Jane Winter

She will lead the CRO's global consulting practice

Medpace acquired by private equity firm for $915m

The CRO will continue to be led by founder and CEO Dr August Troendle

EU flag

Pharma wants review of EMA pharmacovigilance fees

EFPIA among associations to call for ‘balanced and transparent’ funding

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links